Showing results (221-230 of 1,561) with videos related to
Sort By:
Pageof 157
Expert Review of Hematology|September 22, 2017
The management and treatment of acute leukemias in the elderly populationXavier ThomasExpert Review of Hematology|August 1, 2017
Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphomaFrank T Winsett, Daniel J Lewis, Madeleine DuvicExpert Review of Hematology|May 4, 2016
Newborn screening for SCID: lessons learnedBecky J Buelow, James W Verbsky, John M RoutesExpert Review of Hematology|July 18, 2017
Is now the time for molecular driven therapy for diffuse large B-cell lymphoma?Alice Di Rocco, Federico De Angelis, Michela Ansuinelli, et al.Expert Review of Hematology|November 30, 2020
Romiplostim in adults with newly diagnosed or persistent immune thrombocytopeniaMaria L Lozano, Bertrand Godeau, John Grainger, et al.Expert Review of Hematology|September 5, 2020
Copy-number variations in adult patients with chronic immune thrombocytopeniaEmrah Yucesan, Ozden Hatirnaz Ng, Fevzi Firat Yalniz, et al.Expert Review of Hematology|December 23, 2022
Presentations and outcomes among sickle cell disease patients with COVID-19 at a large southern healthcare systemKaren Clarke, Yoo Mee Shin, Mary Ann Kirkconnell Hall, et al.Expert Review of Hematology|December 29, 2022
Real-world treatment patterns and outcomes of triple-class treated patients with multiple myeloma in the United StatesPrateesh Varughese, Robert Smith, Mei Xue, et al.Expert Review of Hematology|June 2, 2021
Measuring prognosis in chronic myeloid leukemia: what's new?Massimo Breccia, Fabio Efficace, Emilia Scalzulli, et al.Expert Review of Hematology|June 2, 2021
An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemiaTamer A Othman, Matthew E Tenold, Benjamin N Moskoff, et al.Pageof 157